연구동향 분석

Optimal diagnosis and disease activity monitoring of intestinal Beh?et’s disease

이현정 천재희 2017년

논문상세정보
인용/피인용

' Optimal diagnosis and disease activity monitoring of intestinal Beh?et’s disease' 의 참고문헌

  • 회결장동맥의 동맥류 파열에 의한 대량 장출혈을 동반한 베체트 장염
    김승업 대한소화기학회지 49 6 400-404 [2007]
  • 베체트장염 진단 가이드라인
    천재희 대한소화기학회지 53 3 187-193 [2009]
  • Vasculitis in Behçet’s disease
    O’Duffy JD. Rheum Dis Clin North Am 16 423-431 [1990]
  • Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease
    Sook Hee Chung Gut and Liver 10 4 574-580 [2016]
  • The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease
    Hye Won Lee Medicine 95 23 e3772- [2016]
  • Temporal changes in the clinical type or diagnosis of Behçet’s colitis in patients with aphthoid or punched-out colonic ulcerations
    Jung HC J Korean Med Sci 6 313-318 [1991]
  • Recent Advances of Endoscopy in Inflammatory Bowel Diseases
    천재희 Gut and Liver 1 2 118-125 [2007]
  • Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease
    Jung YS Inflamm Bowel Dis 17 1594-1602 [2011]
  • Prediction of the clinical course of Behçet’s colitis according to macroscopic classification by colonoscopy
    Kim JS Endoscopy 32 635-640 [2000]
  • Pathological mimics of chronic inflammatory bowel disease
    Shepherd NA. J Clin Pathol 44 726-733 [1991]
  • Pathologic features of Behçet’s syndrome: a review of Japanese autopsy registry data
    Lakhanpal S Hum Pathol 16 790-795 [1985]
  • Mucosal healing predicts the long-term prognosis of intestinal Behçet’s disease
    Yim SM Dig Dis Sci 59 2529-2535 [2014]
  • Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn’s disease
    Schnitzler F Inflamm Bowel Dis 15 1295-1301 [2009]
  • Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort
    Frøslie KF Gastroenterology 133 412-422 [2007]
  • Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
    Rutgeerts P Gut 56 453-455 [2007]
  • Mimicry and deception in inflammatory bowel disease and intestinal Behçet disease
    Grigg EL Gastroenterol Hepatol (N Y) 8 103-112 [2012]
  • Longterm clinical outcomes of Crohn’s disease and intestinal Behcet’s disease
    Jung YS Inflamm Bowel Dis 19 99-105 [2013]
  • Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with intestinal Behcet disease
    Jung YS J Clin Gastroenterol 46 e38-e45 [2012]
  • Laboratory markers in IBD: useful, magic, or unnecessary toys?
    Vermeire S Gut 55 426-431 [2006]
  • Intestinal involvement in Behçet’s disease: review of 136 surgical cases in the Japanese literature
    Kasahara Y Dis Colon Rectum 24 103-106 [1981]
  • Intestinal Behçet’s disease: report of five cases
    Baba S Dis Colon Rectum 19 428-440 [1976]
  • Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?
    Duk Hwan Kim Yonsei Medical Journal 57 1 22- [2016]
  • Intestinal Behcet’s disease
    Yang SK. Intest Res 3 1-10 [2005]
  • International Study Group for Behçet’s Disease
  • Infliximab for induction and maintenance therapy for ulcerative colitis
    Rutgeerts P N Engl J Med 353 2462-2476 [2005]
  • Historical review of so called “simple ulcer” of the intestine
    Muto T. Stomach Intestine 14 739-748 [1979]
  • Gastrointestinal manifestations of Behçet’s disease
    Ebert EC. Dig Dis Sci 54 201-207 [2009]
  • Gastrointestinal manifestations of Behcet’s disease
    Bayraktar Y J Clin Gastroenterol 30 144-154 [2000]
  • Fecal calprotectin as a non-invasive biomarker for intestinal involvement of Behçet’s disease
    Kim DH J Gastroenterol Hepatol 32 595-601 [2017]
  • Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet’s disease
    Jung YS Inflamm Bowel Dis 17 2130-2137 [2011]
  • Differential diagnosis of intestinal Behçet’s disease and Crohn’s disease by colonoscopic findings
    Lee SK Endoscopy 41 9-16 [2009]
  • Diagnostic criteria for Behçet’s disease in 1987, and guidelines for treating Behçet’s disease
    Mizushima Y Saishin Igaku 43 382-391 [1988]
  • Diagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2nd Asian Organization for Crohn’s and Colitis (AOCC) meeting in Seoul
    김은수 Intestinal research 14 3 224-230 [2016]
  • Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet’s disease
    Cheon JH Inflamm Bowel Dis 17 605-613 [2011]
  • Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study
    Turner D Gastroenterology 133 423-432 [2007]
  • Development of consensus statements for the diagnosis and management of intestinal Behçet’s disease using a modified Delphi approach
    Kobayashi K J Gastroenterol 42 737-745 [2007]
  • Development of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study
    Best WR Gastroenterology 70 439-444 [1976]
  • Development and validation of novel diagnostic criteria for intestinal Behçet’s disease in Korean patients with ileocolonic ulcers
    Cheon JH Am J Gastroenterol 104 2492-2499 [2009]
  • Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes
    Bouchon A J Immunol 164 4991-4995 [2000]
  • Crohn’s disease management after intestinal resection: a randomised trial
    De Cruz P Lancet 385 1406-1417 [2015]
  • Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
    Shu Chen Wei Intestinal research 14 4 293-294 [2016]
  • Correlations between endoscopic and clinical disease activity indices in intestinal Behcet’s disease
    Lee HJ World J Gastroenterol 18 5771-5778 [2012]
  • Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn’s disease: a prospective multicentre study of 121 cases. The Groupe d’Etudes Thérapeutiques des Affections Inflammatoires Digestives
    Cellier C Gut 35 231-235 [1994]
  • Colonoscopic findings in intestinal Behçet’s disease
    Lee CR Inflamm Bowel Dis 7 243-249 [2001]
  • Clinical course of intestinal Behcet’s disease during the first five years
    Jung YS Dig Dis Sci 58 496-503 [2013]
  • Chronological changes in the systemic manifestations of intestinal Behcet’s disease and their significance in diagnosis
    Shin SJ Int J Colorectal Dis 25 1371-1376 [2010]
  • Biomarkers of inflammation in inflammatory bowel disease
    Sands BE. Gastroenterology 149 1275.e2-1285.e2 [2015]
  • Behçet’s syndrome
    Cheon JH 165-188 [2010]
  • Behçet’s disease: relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity
    Müftüoğlu AU Int J Dermatol 25 235-239 [1986]
  • Behçet’s disease
    O’Duffy JD. Curr Opin Rheumatol 6 39-43 [1994]
  • Behçet’s disease
    Kaklamani VG Semin Arthritis Rheum 27 197-217 [1998]
  • Behçet’s disease
    Sakane T N Engl J Med 341 1284-1291 [1999]
  • Anti-alphaenolase antibody as a serologic marker and its correlation with disease severity in intestinal Behçet’s disease
    Shin SJ Dig Dis Sci 56 812-818 [2011]
  • Anti-Saccharomyces cerevisiae antibody in intestinal Behçet’s disease patients: relation to clinical course
    Choi CH Dis Colon Rectum 49 1849-1859 [2006]
  • Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn’s disease
    Lee YJ Endoscopy 38 592-597 [2006]
  • An update on the diagnosis, treatment, and prognosis of intestinal Behçet’s disease
    Cheon JH Curr Opin Rheumatol 27 24-31 [2015]
  • Activation markers in Behçet’s disease
    Coskun B Skinmed 4 282-286 [2005]